Tempest Therapeutics Inc (TPST)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $7.64M
Last updated: Nov 17, 2026 at 4:34 PM ET
Tempest Therapeutics Inc (TPST) Stock Chart
Tempest Therapeutics (TPST) has a latest price of $0.33 on Nov 17, 2026. Its price fell 96.4% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 64.3%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $14,731.69 in Oct 2016 and its lowest $0.50 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TPST with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TPST.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 69.4%, and over 6 months it fell 81.6%. The month-end price fell 99.1% over the 3 years through Oct 2026, a compound annual decline of 79.0%.
| Period | Change |
|---|---|
| 1 month | -45.5% |
| 3 months | -69.4% |
| 6 months | -81.6% |
| 12 months | -96.4% |
| 12 months, with dividends | -96.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.1% | -79.0% |
| 5 years | -99.7% | -68.2% |
| 10 years | -100.0% | -64.3% |
Price by Year
Its best calendar year was 2023, when the price rose 282.6%, and its weakest was 2021, when it fell 83.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.50 | -82.7% |
| 2025 | $2.87 | -73.6% |
| 2024 | $10.85 | -81.0% |
| 2023 | $57.22 | +282.6% |
| 2022 | $14.95 | -78.2% |
| 2021 | $68.66 | -83.5% |
| 2020 | $417.22 | -68.2% |
| 2019 | $1,314.04 | -15.2% |
| 2018 | $1,549.94 | -62.1% |
| 2017 | $4,092.14 | -8.5% |
Trading Range
The price is 50.2% below its 50-day average of $0.66 and 76.0% below its 200-day average of $1.36.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.33 | |
| 50-day average | $0.66 | -50.2% |
| 200-day average | $1.36 | -76.0% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.04 |
| Largest fall, 1 year | -96.5% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TPST
What is TPST's 1-year price change?
Tempest Therapeutics's price fell 96.4% over the past 12 months. With dividends included, the 12-month total return was -96.4%.
What is TPST's 5-year price change?
Tempest Therapeutics's month-end price fell 99.7% over the 5 years through Oct 2026, a compound annual decline of 68.2%. These figures leave out dividends.
What is TPST's beta?
Tempest Therapeutics's 1-year beta against the S&P 500 is 1.04, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 96.5%.
Is the TPST chart free?
Yes. Advanced Charting for TPST is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TPST pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors